baber/WOPTO huggingface dataset:
Patent MX-2016016530-A (MX)
Title: Phosphatidylinositol 3-kinase inhibitors.
Inventor: GARY PHILLIPS
IPC: A61P9/10
Filed: 2015-06-10
Abstract: The present application provides the compounds of formula (J), or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof, wherein n, W, A', B', R1, R2, and R3 are described herein. The compounds are inhibitors to the activities of phosphatidylinositol 3-kinase (PI3K) and are useful for treating conditions mediated by one or more PI3K isoforms. The present application further provides pharmaceutical compositions that include a compound of formula (I), or pharmaceutically acceptable salts, isomers, tautomer, or mixture thereof, and methods of using these compounds and compositions for treating conditions mediated by one or more PI3K isoforms.
Patent MX-2017004378-A (MX)
Title: Pharmaceutical formulations of pegylated liposomes and blood coagulation factors.
Inventor: WILLIAM HENRY
IPC: A61K38/37
Filed: 2015-10-06
Abstract: The present invention provides a pharmaceutical composition for subcutaneous administration comprising a blood factor and a colloidal particle comprising about 0.5 to 20 mole percent of an amphipathic lipid derivatized with a biocompatible hydrophilic polymer, wherein the blood factor is not encapsulated in said colloidal particle.
Patent MX-2017004695-A (MX)
Title: Mri imaging of amyloid plaque using liposomes.
Inventor: Mayank srivastava
IPC: A61K49/04
Filed: 2015-10-08
Abstract: Provided are aromatic compounds, phospholipid-polymer-aromatic conjugates comprising the aromatic compounds, and liposome compositions including the phospholipid- polymer-aromatic conjugates. The liposomal compositions may be useful for imaging of Alzheimer's Disease, for example, imaging of the amyloid-ß plaque deposits characteristic of Alzheimer's Disease.
Patent MX-2017007033-A (MX)
Title: Energy absorbing apparatus.
Inventor: ANDREW KARL DIEHL
IPC: B66D5/18
Filed: 2015-12-04
Abstract: Described herein are energy absorbing apparatus and methods of use that utilise varying energy absorbing relationships between the apparatus members to absorb an energy input. The energy absorbing process occurs via a material forming process.
Patent MX-2017007476-A (MX)
Title: Botulinum toxin prefilled container.
Inventor: MARKUS VOGT
IPC: A61K38/48
Filed: 2015-12-22
Abstract: The present invention relates to a prefilled glass container, such as a prefilled glass syringe, comprising an aqueous botulinum toxin formulation. The aqueous botulinum toxin formulation in the prefilled container is stable at low to ambient temperature for a prolonged time period. Furthermore, the present invention relates to a kit comprising the botulinum toxin prefilled container, and to the use of the botulinum toxin prefilled container in therapeutic and cosmetic applications.
Patent MX-2017008896-A (MX)
Title: Composition comprising calcium magnesium compound(s) as compacts.
Inventor: CHOPIN THIERRY
IPC: C22B1/20
Filed: 2016-01-08
Abstract: Composition comprising at least one calcium-magnesium compound and a second compound chosen in the group consisting of B2O3, NaO3, calcium aluminate, calcium silicate, calcium ferrite such as Ca2Fe2O5 or CaFe2O4, Al, Mg, Fe, Mn, Mo, Zn, Cu, Si, CaF2 ,, C, CaC2, CaSi, CaMg, CaFe, FeMn, FeSi, FeSiMn, FeMo; Ti02, an oxide or a hydroxide of molybdenum, copper, zinc, and their mixture, in the form of compacts formed with compacted and shaped particles of calcium-magnesium compounds, having a Shatter Test Index of less than 20% and the manufacturing process thereof.
Patent MX-2017013808-A (MX)
Title: Igf-1r antibody and its use for the diagnosis of cancer.
Inventor: ALEXANDRA JOUHANNEAUD
IPC: C07K16/28
Filed: 2016-04-27
Abstract: The present disclosure relates to IGF-IR (insulin like growth factor receptor -1) antibodies characterized by CDR sequences a, to be used in detection methods of IGF-IR expressing tumoral cells.
Patent MX-2017014686-A (MX)
Title: Power supply control device and power supply control method.
Inventor: TETSUYA HAYASHI
IPC: H02M3/00
Filed: 2015-05-20
Abstract: This power supply control device is provided with: a DC power supply having a positive electrode and a negative electrode; a load electrically connected to the DC power supply; a relay connected in series on a current path from the positive electrode through the load to the negative electrode; a switching element connected in series on the current path; and a controller that controls the relay and the switching element. In the case of electrically interrupting the current path, the controller switches the switching element to an off state and then switches the relay to an off state.
Patent MX-2018002367-A (MX)
Title: Method for determining porosity associated with organic matter in a well or formation.
Inventor: YAOMING MU
IPC: E21B49/08
Filed: 2016-09-06
Abstract: A method for determining porosity associated with organic matter (PAOM) in a well or formation is provided. A system for performing the method is also provided.
Patent MX-2018002945-A (MX)
Title: Systems and methods for tracking information.
Inventor: GABRIEL ENRIQUE REINA
IPC: G06F15/173
Filed: 2016-09-09
Abstract: Systems are disclosed comprising, for example. a non-transitory, computer-readable storage medium on which a database management system is stored and configured to allow access and indexing of content items related to an investigation in a corpora of electronically stored content, a computer machine comprising a processor in communication with the storage medium configured to receive a first data associated with the investigation, receive a second data associated with the investigation, link the first data and the second data with the investigation, associate, by the processor, the first data with the second data, and report, by the processor, an investigative conclusion based on the association of the first data and the second data. Methods of database management for investigations are also disclosed.
Patent MX-2018004543-A (MX)
Title: Communication outlet with shutter mechanism and wire manager.
Inventor: CHARLES BRAGG
IPC: H01R13/58
Filed: 2016-10-11
Abstract: A communication connector with a housing door pivotably coupled to a housing. The housing door is rotatable with respect to the housing between open and closed positions. The housing door is configured to be electrically connected to at least one grounding component of a cable. The housing has a door gripping portion. One of the housing door and the door gripping portion has a projection configured to engage another one of the housing door and the door gripping portion when the housing door is in the closed position. When so engaged, the projection is configured to electrically connect the housing door with the housing to thereby electrically connect the at least one grounding component with the housing.
Patent MX-2018012267-A (MX)
Inventor: BORG ZAKARY JAMES
IPC: B65D71/50
Filed: 2018-08-21
Abstract: Se proporciona un transportador de contenedores y su método de fabricación. El transportador de contenedores puede incluir un cuerpo moldeado integralmente con una superficie superior, una superficie inferior, y una pluralidad de estructuras anulares. Cada estructura anular puede conectar con lo menos una estructura anular adyacente y puede incluir una arista circunferencial con una pluralidad de rebordes, configurados colectivamente para asegurar un contenedor. Un mango formado integralmente puede extenderse ascendentemente desde el cuerpo del transportador de contenedores. El mango puede incluir una región de agarre y una región bifurcada que forma un par de brazos que conectan con el cuerpo y apoya la región de agarre en una configuración vertical en un estado no inclinado. Los brazos pueden flexionarse de modo que una intersección de la región bifurcada y la región de agarre se mueve para ajustar una flexión descendente del mango cuando se aplica una fuerza inclinada des.
Patent MX-2019001860-A (MX)
Title: Regimens and methods of treating multiple sclerosis using ofatumumab.
Inventor: ERIK WALLSTRÖM
IPC: A61P25/00
Filed: 2017-08-11
Abstract: The disclosure is directed to treatment regimens for treating Multiple Sclerosis (MS). These methods utilize administration of ofatumumab, an anti-CD20 monoclonal antibody, to the patient during a loading dose regimen and a maintenance regimen.
Patent MX-2019001862-A (MX)
Title: System and structure for the rotary mounting of peripheral devices.
Inventor: VELAZQUEZ EUFRACIO JOSUE ALEJANDRO
IPC: G03B17/56
Filed: 2019-02-14
Abstract: The present invention relates to a system and structure for the rotary type mounting of peripheral devices on the forearm and wrist of a user, thus improving the stability therein and the weight-balanced distribution. Said system possesses a rotor with an articulated type arm structure.
Patent MX-2019001979-A (MX)
Title: PPARy AGONIST FOR TREATMENT OF BLOOD CANCERS.
Inventor: CHRISTOS MANTZOROS
IPC: A61K31/7088
Filed: 2017-08-18
Abstract: Methods of treatment of blood cancers including leukemia and myeloma with the compound of formula (I) known as INT131:.
Patent MX-2019004495-A (MX)
Title: Flame resistant material and resultant products.
Inventor: MICHAEL OWEN WELLS
IPC: C09K21/12
Filed: 2017-10-19
Abstract: Disclosed herein are compositions, formulations, applications, and methods of making a fire resistant material. The fire resistant material is a transparent acrylic material that incorporates a primary polymer, nanostructured fillers, and crosslinkers. The nanostructured filler is polyhedral oligomeric silsesquioxane (POSS) or a POSS derivative that has a cage like structure. The fire resistant material may also include various components such as brominated additives and phosphorous based synergists. The fire resistant material may be used for various applications including wall claddings and glazings.
Patent MX-2019011925-A (MX)
Title: Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension.
Inventor: DAVID ELLIS
IPC: A61P27/06
Filed: 2017-04-11
Abstract: Prostaglandin conjugates and derivatives and methods for their use to treat glaucoma and/or lower intraocular pressure are disclosed. Additionally, ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma and elevated intraocular pressure are disclosed. Such compositions comprise an effective amount of prostaglandin conjugates or derivatives of the present invention.
Patent MX-2019014093-A (MX)
Title: Fine blanking press and method for operating the same.
Inventor: LOZANO BONET JOSÉ
IPC: B21D24/14
Filed: 2019-11-25
Abstract: The disclosure pertains to a fine blanking press comprising a first press unit comprising a first press drive for driving the first press unit in a first driving movement during a fine blanking process step, and a second press unit wherein the second press unit is driven in a second driving movement at least partially during the first driving movement of the first press unit, and wherein a force control unit exerts a counter force against a force exerted by the first press unit during its first driving movement, and wherein the force control unit comprises at least one sensor and a controller operative to receive measuring data collected by the at least one sensor, and wherein the controller is configured to carry out a closed loop control on basis of the received measuring data. The disclosure further pertains to a method for operating a fine blanking press.
Patent MX-2019014745-A (MX)
Title: Method for in situ mixing of liquid compositions with offset liquid influx.
Inventor: CHONG GU
IPC: B01F3/08
Filed: 2017-06-08
Abstract: Methods for in situ mixing of two or more different liquid compositions in a container by employing one or more liquid influxes that are offset by 1-50° from a longitudinal axis of such container. Such offset or angled liquid influxes function to increase the impact of available kinetic energy on the mixing result and in turn improve homogeneity and stability of the finished liquid consumer product so formed.
Patent MX-2020000636-A (MX)
Title: Synthetic proteins and therapeutic uses thereof.
Inventor: CHARLTON KEITH ALAN
IPC: A61K39/00
Filed: 2018-07-18
Abstract: The present disclosure relates to compositions and methods for treating disease, particularly, the disclosure relates to synthetic proteins and their use for treating cancer.
Patent MX-2020000693-A (MX)
Title: 1,8-naphthyridinone compounds and uses thereof.
Inventor: CHAKRAVARTY SARVAJIT
IPC: A61K31/4985
Filed: 2018-07-18
Abstract: 1,8-naphthyridinone compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
Patent MX-2020002108-A (MX)
Title: Autonomous systems and methods for wellbore intervention.
Inventor: BOWMAN DAVID SYDNEY
IPC: E21B33/072
Filed: 2018-08-24
Abstract: An autonomous intervention system (10) configured to perform an intervention operation in a wellbore (12) comprises a tool housing (20) having a tool storage compartment (21) configured to house an intervention tool (18). A valve arrangement (22) permits selective communication of tools and fluid between the tool housing (20) and the wellbore (12). The intervention system (10) is configured to move in response to an activation event between a tool storage configuration in which the tool housing (20) is isolated from the wellbore (12) by the valve arrangement (22) and an activated configuration in which the valve arrangement (22) is open and the tool housing (20) communicates with the wellbore (12) to permit deployment of the intervention tool (18) by a tool deployment arrangement (30).
Patent MX-2020003028-A (MX)
Title: Auto-braking for an electromagnetic machine.
Inventor: ROELLE MATTHEW
IPC: H02H7/08
Filed: 2018-09-20
Abstract: Systems and methods are provided for braking a translator of a linear multiphase electromagnetic machine. The system detects a fault event, and in response to detecting the fault event, causes the translator to brake using an electromagnetic technique. Braking includes causing the translator to stop reciprocating, by applying a force opposing an axial motion, which may occur within one cycle, or over many cycles. The fault event may include, for example, a fault associated with an encoder, a controller, an electrical component, a communications link, a phase, or a subsystem. The system includes a power electronics system configured to apply current to the phases. The system may use position information, current information, operating parameters, or a combination thereof to brake. Alternatively, the system need not use position information, current information, and operating parameters, and may brake the translator independent of such information.
Patent MX-2020003930-A (MX)
Title: Transmitter and method for generating additional parity thereof.
Inventor: KIM KYUNG-JOONG
IPC: H04L1/00
Filed: 2017-08-29
Abstract: A transmitter is provided. The transmitter includes: a Low Density Parity Check (LDPC) encoder configured to encode input bits to generate an LDPC codeword including the input bits and parity bits to be transmitted to a receiver in a current frame; a repeater configured to repeat, in the LDPC codeword, at least some bits of the LDPC codeword in the LDPC codeword so that the repeated bits are to be transmitted in the current frame; a puncturer configured to puncture some of the parity bits; and an additional parity generator configured to select at least some bits of the LDPC codeword including the repeated bits, and generate additional parity bits to be transmitted in a previous frame of the current frame.
Patent MX-2020005007-A (MX)
Title: Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders.
Inventor: HEYWARD PHILIP MYERS
IPC: A61K31/12
Filed: 2018-11-26
Abstract: The present invention relates to relates to a pharmaceutical composition comprising butein (BTN) and sulfuretin (SLF) and/or isoliquiritigenin (ILQ), or pharmaceutically acceptable salts, tautomers, solvates and/or derivatives thereof. The invention further relates to the use of said compositions in the treatment of diabetes or an associated disease, condition and/or disorder such as prediabetes and/or diet-induced impairment of glucose regulation, and the use of compositions comprising sulfuretin (SLF) or isoliquiritigenin (ILQ) alone for said treatments.
Patent MX-2020005601-A (MX)
Title: Endovascular apparatus.
Inventor: HOYE JESSICA LYNN ROLL
IPC: A61M25/00
Filed: 2017-11-30
Abstract: An endovascular apparatus includes a first cannula, a second cannula, and an operator handle. The first cannula has a proximal end, a distal end, and a first lumen. The second cannula is slidably coupled to the first cannula. The second cannula has a proximal end portion, a distal end portion, and a second lumen. The distal end portion is extendable in a distal direction beyond the distal end of the first cannula. The operator handle is operably coupled to the second cannula. The operator handle may be configured to articulate the distal end portion of the second cannula relative to the first cannula. The second cannula may include an articulation joint. Optionally, the operator handle may be configured to extend, retract, and rotate the second cannula relative to the first cannula. Also, optionally, the endovascular apparatus may include a magnetic coupler.
Patent MX-2020006599-A (MX)
Title: Compositions and methods for treating cns disorders.
Inventor: SALITURO FRANCESCO G
IPC: A61K31/57
Filed: 2018-12-21
Abstract: Provided herein are compounds of Formula (I-I): and pharmaceutically acceptable salts thereof; wherein p, R<sup>1</sup>, R<sup>3a</sup>, R<sup>2a</sup>, R<sup>11a</sup>, R<sup>11b</sup>, R<sup>6a</sup>, and R<sup>6b</sup> are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I-X) and methods of using the compounds, <i>e.g</i>., in the treatment of CNS-related disorders.
Patent MX-2020007402-A (MX)
Title: Polyurethane comprising formulations with isocyanate functionality.
Inventor: MANGELSCHOTS NICOLE
IPC: C09J175/06
Filed: 2019-01-10
Abstract: A urethane group-containing reactive polyisocyanate composition is disclosed which contains not more than 1 wt% of monomeric starting di-isocyanate based on the total weight of said polyisocyanate composition, having an NCO value in the range 0.1-15%, and wherein said composition comprises urethane groups and allophanate groups and wherein the ratio of allophanate groups over urethane groups is between 0.05 and 100.
Patent MX-2020007710-A (MX)
Title: Automated device for staining multiple histological samples.
Inventor: BELTRÁN RAMÍREZ JESÚS RAÚL
IPC: G01N1/31
Filed: 2020-07-20
Abstract: The present invention discloses an automated device for staining multiple histological samples having several slides, which allows performing the staining process on more than one sample automatically and simultaneously using different types of reagents at the same time. Also, it possesses a chamber storing various containers and a microcontroller activating an electro-valve supplying the diverse reagents found in the containers in the same staining cycle. Further, it has a water supply system for washing or rinsing the samples and a drainage system to dispose of solutions and water used during the staining process.
Patent MX-2020007726-A (MX)
Title: Methods for x-ray imaging of a subject using multiple-energy decomposition.
Inventor: ZHAO YING
IPC: G01N23/04
Filed: 2019-01-20
Abstract: Methods for quantitatively separating x-ray images of a subject having three or more component materials into component images using spectral imaging or multiple-energy imaging with 2D radiographic hardware implemented with scatter removal methods. The multiple-energy system may be extended by implementing DRC multiple energy decomposition and K-edge subtraction imaging methods.
Patent MX-2020010576-A (MX)
Title: Tri-substituted aryl and heteroaryl derivatives as modulators of pi3-kinase and autophagy pathways.
Inventor: STOCKING EMILY M
IPC: C07D498/08
Filed: 2019-04-09
Abstract: The present disclosure relates to tri-substituted aryl and heteroaryl derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for modulating autophagy or preventing, reversing, slowing or inhibiting the PI3K-AKT-MTOR pathway, and methods of treating diseases that are associated with autophagy or the PI3K-AKT-MTOR pathway.
Patent MX-2020010911-A (MX)
Title: Capacitive control system, in particular a steering wheel column integrated module of an automotive vehicle.
Inventor: WOZNIAK MAREK
IPC: H03K17/975
Filed: 2018-04-16
Abstract: The present invention relates to a capacitive control system (1), in particular a steering wheel column integrated module of an automotive vehicle, comprising a support (6), at least one control element (3, 4, 5) disposed displaceably within the support (6), at least one first capacitive activating region (81a-81e) adjacent to a second capacitive activating region (71a-71e) and disposed beneath and cooperating with said control element (3, 4, 5) to change the distance and thus electrical capacitance between the first (81a-81e) and the second (71a-71e) capacitive activating regions. In order to increase robustness of the capacitive control system (1) said at least one first capacitive activating region (81a-81e) is disposed at a metal, deformable arm (83) haptically engaged with said control element (3, 4, 5), wherein said haptical engagement is provided by a shaped projection (82) or recess of the arm (83) cooperating with at least one internal recess (32, 42, 52) or projection of said control element (3, 4, 5), and the distance between the first (81a-81e) and the second (71a-71e) capacitive activating regions remains greater than zero.
Patent MX-2020011718-A (MX)
Title: Solid forms of an fgfr inhibitor and processes for preparing the same.
Inventor: TAO MING
IPC: A61K31/519
Filed: 2019-05-03
Abstract: The present disclosure relates to solid forms and polymorphs of compound (1): 3-(2,6-difluoro-3,5-dimethoxyphenyl) -l-ethyl-8-(morpholin-4-ylmethyl)-l,3,4,7-tetrahydro-2H-pyrrolo [3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of the FGFR-associated or mediated diseases such as cancer.
Patent MX-2020011857-A (MX)
Inventor: PENG SHENG
IPC: C09K5/04
Filed: 2019-10-29
Abstract: La presente invención se relaciona con composiciones refrigerantes que comprenden al menos una fluoroolefina, al menos un lubricante y una cantidad eficaz de al menos un inhibidor en donde el inhibidor está presente en la fluoroolefina y el lubricante.
Patent MX-2020013678-A (MX)
Title: Prosthetic foot.
Inventor: HUOT GRÉGORY
IPC: A61F2/50
Filed: 2019-07-08
Abstract: A prosthetic foot comprising an internal keel (1) and an encapsulation material (2). The keel (1) is made of two parts (3,4), namely an elastic ankle (3) and an elastic blade (4), to ensure a behaviour of the prosthesis as close as possible to the biomechanics of a sound human foot (plantar flexion, dorsiflexion, inversion, eversion). The materials and design used for the keel (1) allow storing and releasing strain energy at the right phases of the gait cycle. Elastomeric foams act as safety features in specific areas to prevent keel overloading. The keel (1) is preferably encapsulated into two types of foam to fill internal space and as cosmetic feature as it has a human foot shape.